Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series.
Antoniou
Tony
T
Yoong
Deborah
D
Beique
Lizanne
L
Chirhin
Steve
S
Rachlis
Anita
A
Gough
Kevin
K
Loutfy
Mona R
MR
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000863:Antacids / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012189:Retrospective Studies
D000863:Antacids; D044966:Anti-Retroviral Agents; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate